相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Xiefeng Yang et al.
BMC MEDICAL IMAGING (2022)
Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas
Xiefeng Yang et al.
ACTA RADIOLOGICA (2021)
Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas
Jun Lu et al.
MAGNETIC RESONANCE IMAGING (2021)
MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas
Craig Horbinski et al.
NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Analysis of Mutant Isocitrate Dehydrogenase 1 Immunoexpression, Ki-67 and Programmed Death Ligand 1 in Diffuse Astrocytic Tumours : Study of Single Center in Bandung, Indonesia
Hendrikus Masang Ban Bolly et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2021)
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Radhika Mathur et al.
NEURO-ONCOLOGY (2020)
In Vivo Molecular Profiling of Human Glioma Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging
Johann-Martin Hempel et al.
CLINICAL NEURORADIOLOGY (2019)
Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status
Harpreet Hyare et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI
Jia Shen Jiang et al.
ACADEMIC RADIOLOGY (2019)
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033
Pierre Bady et al.
ACTA NEUROPATHOLOGICA (2018)
Mutant ATRX: uncovering a new therapeutic target for glioma
Santiago Haase et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics
Naeim Bahrami et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status
Guenther Grabner et al.
EUROPEAN RADIOLOGY (2017)
In vivo molecular profiling of human glioma using diffusion kurtosis imaging
Johann-Martin Hempel et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Apparent diffusion coefficient maps obtained from high b value diffusion-weighted imaging in the preoperative evaluation of gliomas at 3T: comparison with standard b value diffusion-weighted imaging
Qiang Zeng et al.
EUROPEAN RADIOLOGY (2017)
Radiomic features predict Ki-67 expression level and survival in lower grade gliomas
Yiming Li et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging
Z. Xing et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2017)
Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index
Ren Yan et al.
NEURORADIOLOGY (2016)
Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma
Yoon Seong Choi et al.
RADIOLOGY (2016)
IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma
Ailiang Zeng et al.
ONCOTARGET (2015)
Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation
Rifeng Jiang et al.
ONCOTARGET (2015)
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
Heather E. Leeper et al.
ONCOTARGET (2015)
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
Philipp Kickingereder et al.
SCIENTIFIC REPORTS (2015)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Principles of T2*- Weighted Dynamic Susceptibility Contrast MRI Technique in Brain Tumor Imaging
Mark S. Shiroishi et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Kasthuri Kannan et al.
Oncotarget (2015)
Combined Value of Susceptibility-Weighted and Perfusion-Weighted Imaging in Assessing WHO Grade for Brain Astrocytomas
Xiao-chun Wang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
M. C. Chamberlain
NEUROLOGY (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples
Jinquan Cai et al.
ONCOTARGET (2014)
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
Benedikt Wiestler et al.
ACTA NEUROPATHOLOGICA (2013)
Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status
Andrea Romano et al.
EUROPEAN RADIOLOGY (2013)
Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme
Leonard Sunwoo et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Identifying Ki-67 specific miRNA-MRNA interactions in malignant astrocytomas
Yanwei Liu et al.
NEUROSCIENCE LETTERS (2013)
Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma
J. A. Carrillo et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging
Won-Jin Moon et al.
NEURORADIOLOGY (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy Study
S. J. Price et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading
Andres Server et al.
NEURORADIOLOGY (2011)
An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging
Sylvia Drabycz et al.
NEUROIMAGE (2010)
Semiquantitative Assessment of Intratumoral Susceptibility Signals Using Non-Contrast-Enhanced High-Field High-Resolution Susceptibility-Weighted Imaging in Patients with Gliomas: Comparison with MR Perfusion Imaging
M. J. Park et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps
Kyrre E. Emblem et al.
RADIOLOGY (2008)
The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas
Anne Linn Johannessen et al.
PATHOLOGY & ONCOLOGY RESEARCH (2006)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
